WO2025133162 - RECOMBINANT PROTEIN EXPRESSION

National phase entry is expected:
Publication Number WO/2025/133162
Publication Date 26.06.2025
International Application No. PCT/EP2024/087965
International Filing Date 20.12.2024
Title **
[English] RECOMBINANT PROTEIN EXPRESSION
[French] EXPRESSION DE PROTÉINES RECOMBINANTES
Applicants **
NOVOZYMES A/S
Inventors
OLSEN, Carsten, Lillelund
ANDERSEN, Rasmus, Lund
NIELSEN, Michael, Lynge
BECH, Pernille, Kjersgaard
Priority Data
23218655.1   20.12.2023   EP
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2438
EPO Filing, Examination, Granting9781
Japan Filing, Examination, Granting2154
South Korea Filing, Examination, Granting2066
USA Filing, Examination, Granting5340
MasterCard Visa
Total: 21,779

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The present invention relates to inducible promoters, and to methods of protein production, wherein recombinant cells are cultivated in a cultivation medium comprising acetate. The invention further relates to formulations and compositions obtained with the method of the invention.[French] La présente invention concerne des promoteurs inductibles et des procédés de production de protéines, des cellules recombinantes étant cultivées dans un milieu de culture comprenant de l'acétate. L'invention concerne en outre des formulations et des compositions obtenues au moyen du procédé de l'invention.